JTCS Concomitant Website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Frank A. Baciewicz, Jr
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baciewicz, F. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baciewicz, F. A., Jr
Related Collections
Right arrow Coronary disease

J Thorac Cardiovasc Surg 2003;126:2108-2109
© 2003 The American Association for Thoracic Surgery

Letter to the editor

Bivalirudin as alternative to both danaparoid and heparin in off-pump coronary artery bypass grafting

Frank A. Baciewicz, Jr, MDa

a Cardiothoracic Surgery, Wayne State University, School of Medicine, Detroit, MI 48201, USA

The first 20% of the full text of this article appears below.

To the Editor:

I enjoyed the recent article "Heparin Versus Danaparoid in Off-Pump Coronary Bypass Grafting: Results of a Prospective Randomized Clinical Trial" by Carrier and colleagues.1 I favor off-pump coronary artery bypass grafting . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The American Association for Thoracic Surgery.